ClinicalTrials.gg
RecruitingNCT07207512EFT-PGDUpdated Sep 2, 2026

Emotion-Focused Therapy in the Treatment of Prolonged Grief Disorder

An interventional study of Emotion-Focused Therapy for Grief and Self-help intervention based on EFT in Prolonged Grief Disorder (PGD), sponsored by Universidad Pontificia Comillas. Recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Universidad Pontificia Comillas · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn if Emotion-Focused Therapy (EFT) works to reduce symptoms of Prolonged Grief Disorder (PGD) in adults. PGD happens when the pain of losing a loved one lasts a long time and causes serious problems in daily life.

  • The main questions this study aims to answer are:

    1. Does EFT lower grief symptoms in adults with PGD?
    2. Does EFT also help with related problems, such as anxiety, depression, trauma, and overall distress?
  • Who can take part:

Adults (18 years or older) who lost a loved one at least 6 months ago and meet the criteria for PGD.

- What will happen in the study:

Participants will be randomly assigned to one of two groups:

  1. EFT group: 8 to 10 weekly, face-to-face therapy sessions with a trained therapist.
  2. Self-help group: 10 weekly self-help exercises based on EFT, completed on their own.

    • All participants will complete questionnaires on grief, mood, and well-being before starting, during the study, at the end of treatment (12 weeks), and again at 5 months and 12 months after starting.
    • In the EFT group, the therapeutic relationship will also be measured during sessions 3 and 8.
    • Why this study is important:

Most current treatments for grief are based on cognitive-behavioral therapy, but not everyone benefits from them. EFT is a promising therapy that focuses on emotions and has shown positive results for other mental health problems. This trial will test if EFT can be an effective treatment for people struggling with prolonged grief.

02

Conditions studied

  • Prolonged Grief Disorder (PGD)

Keywords

  • grief
  • bereavement
  • prolonged grief disorder
  • grief with complications
  • Emotion-Focused Therapy
  • PGD
  • Randomized Controlled Trial
  • RCT
  • study protocol
  • Treatment Effectiveness
03

In context

Prolonged Grief Disorder

40 studies on the registry are indexed under Prolonged Grief Disorder; 14 are open to participants now.

This study's planned enrollment of 128 is above the median of 73 across 36 interventional studies indexed under Prolonged Grief Disorder.

Browse Prolonged Grief Disorder studies →

Lead sponsor

Universidad Pontificia Comillas is the lead sponsor of 19 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults (≥18 years).
  • Undergoing a grief process (including perinatal grief).
  • Meeting ICD-11 diagnostic criteria for Prolonged Grief Disorder, assessed with the Traumatic Grief Inventory - Clinician Administered (TGI-CA); death occurred six months or more prior to assessment; PG-13-R score ≥30.
  • Provision of .
  • Stable psychopharmacological medication for at least six weeks prior to therapy onset, with physician approval to maintain stability during the intervention.

Exclusion criteria

Exclusion Criteria:

  • Concurrent psychological treatment
  • Bereavement occurring less than six months prior to the loss
  • Substance abuse
  • Eating disorder
  • Psychosis;
  • Organic brain syndrome
  • Suicide risk
  • Risk of harm to others.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
128 participants (estimated)

Study arms

  • Experimental
    Emotion-Focused Therapy for Grief

    Behavioral: Emotion-Focused Therapy for Grief

  • Placebo comparator
    self-help intervention based on Emotion-Focused Therapy

    Behavioral: Self-help intervention based on EFT

Interventions

  • BehavioralEmotion-Focused Therapy for Grief

    The EFT intervention will follow the model described in EFT for grief. Its main goal is to transform core emotional pain (e.g., chronic shame) by activating change-inducing emotions (e.g., assertive anger), a process described as "changing emotion with emotion." This work takes place within a safe and supportive therapeutic relationship, characterized by the therapist's empathic, accepting, and compassionate stance. Therapists remain attuned to emotional markers (e.g., self-criticism, unfinished business) that signal opportunities for targeted work on specific affective problems, which are usually addressed through experiential tasks such as the Empty-Chair for Unfinished Business. Although EFT is transdiagnostic, grief work has certain distinctive features, such as the central role of experiencing grief-related sadness and fostering a sense of connection with the deceased.

  • BehavioralSelf-help intervention based on EFT

    The self-help intervention consists of 10 written exercises designed to address different aspects of grief. These include psychoeducation, emotional regulation, focusing on bodily awareness, softening self-criticism, reducing avoidance, managing anxiety and fear, clarifying confusing emotional reactions, processing trauma, imaginal dialogues with the deceased, and cultivating compassion.

06

What researchers measure

Primary outcomes

  1. Prolonged Grief Scale 13 - Revised

    Higher scores indicate greater symptomatology of Prolonged Grief Disorder; a score of 30 or higher meets the clinical threshold for Prolonged Grief Disorder.

    Time frame: From enrollment to the end of the research at 1 year follow-up

Secondary outcomes

  1. Centrality of Event Scale

    Higher scores indicate greater trauma symptomatology

    Time frame: From enrollment to the end of the reserch at 1 year follow-up

  2. Clinical Outcomes in Routine Evaluation-10

    Higher scores indicate greater psychological distress

    Time frame: From enrollment to the end of the reserch at 1 year follow-up

  3. Patients Health Questionnarie 9

    Higher scores indicate greater psychological distress

    Time frame: From enrollment to the end of the reserch at 1 year follow-up

  4. Generalized Anxiety Disorder-7 Scale

    Higher scores indicate greater GAD symptomatology

    Time frame: From enrollment to the end of the reserch at 1 year follow-up

  5. TGI-CA

    Proportion of participants no longer meeting ICD-11 diagnostic criteria for prolonged grief disorder, assessed with the Traumatic Grief Inventory - Clinician Administered (TGI-CA).

    Time frame: Post-treatment (12 weeks), 5-month and 12-month follow-up

07

Study locations

1 of 1 sites recruiting
  • Unidad Clínica de Psicología de la Universidad Pontificia Comillas (UNINPSI)
    Madrid, Madrid 28036, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Sep 2029, 40 months after the start.

Of 27 interventional studies with no phase under Prolonged Grief Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 57. This study's planned 40 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 26, 2025
First posted
Oct 6, 2025
StartActual
Apr 6, 2026
Primary completionEst.
Sep 1, 2029
CompletionEst.
Sep 1, 2029
Last update
Sep 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07207512
Lead sponsor
Universidad Pontificia Comillas
Responsible party
José Gamoneda Larripa (Associate professor, Universidad Pontificia Comillas) — Principal investigator
First posted
Oct 6, 2025
Start date
Apr 6, 2026
Primary completion
Sep 1, 2029 (estimated)
Completion
Sep 1, 2029 (estimated)
Last update
Sep 2, 2026

Study contacts

José Gamoneda, PhD
Contact
jgamoneda@comillas.edu
+34636894995
Rafael Jódar, PhD
Contact
rafajodar@comillas.edu
91 734 39 50
José Gamoneda, PhD
principal investigator · Universidad Pontificia Comillas

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion